Role of ephrin-A1 in lung metastasis
Project/Area Number |
25870760
|
Research Category |
Grant-in-Aid for Young Scientists (B)
|
Allocation Type | Multi-year Fund |
Research Field |
General medical chemistry
Respiratory surgery
|
Research Institution | Tokyo Women's Medical University |
Principal Investigator |
|
Project Period (FY) |
2013-04-01 – 2015-03-31
|
Project Status |
Completed (Fiscal Year 2014)
|
Budget Amount *help |
¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000)
Fiscal Year 2014: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2013: ¥2,600,000 (Direct Cost: ¥2,000,000、Indirect Cost: ¥600,000)
|
Keywords | 転移 / Eph / ephrin / ADAM / がん |
Outline of Final Research Achievements |
It has been reported that overexpression of ephrin-A1 is positively correlated with prognosis in various cancers such as hepatocellular carcinoma. However, the detailed function remains unclear. Therefore, I focused on metastasis that get worse their prognosis in cancer patients and analyzed functions of ephrin-A1 in lung metastasis. I found that ADAM12 identified as a proteinase against ephrin-A1, cleaved ephrin-A1 in primary tumors, and the the serum level is increased. Activated EphA2 by cleaved ephrin-A1 is immediately endocytosed and undergone proteolysis and therby localization of VE-cadherin at the plasma membrane is lost. As a result of destabilization of EphA2 and VE-cadherin at the plasma membrane in lung vascular endothelial cells leads to hyper-permeability and enhances lung metastasis. A neutralizing antibody against ephrin-A1 is effective for lung metastasis. I would like to develop anti-ephrin-A1 therapeutic drugs.
|
Report
(3 results)
Research Products
(12 results)
-
-
-
[Journal Article] ZFC3H1, a Zinc Finger Protein, Modulates IL-8 Transcription by Binding with Celastramycin A, a Potential Immune Suppressor2014
Author(s)
Tomita T, Ieguchi K, Coin F, Kato Y, Kikuchi H, Oshima Y, Kurata S, Maru Y
-
Journal Title
PLoS One
Volume: 30
Issue: 9
Pages: e108957-e108957
DOI
Related Report
Peer Reviewed / Open Access / Acknowledgement Compliant
-
-
[Journal Article] An integrin binding-defective mutant of insulin-like growth factor-1 (R36E/R37E IGF1) acts as a dominant-negative antagonist of the IGF1 receptor (IGF1R) and suppresses tumorigenesis but still binds to IGF1R2013
Author(s)
Fujita M, Ieguchi K, Cedano-Prieto DM, Fong A, Wilkerson C, Chen JQ, Wu M, Lo SH, Cheung AT, Wilson MD, Cardiff RD, Borowsky AD, Takada YK, Takada Y
-
Journal Title
Journal of Biological Chemistry
Volume: 288
Issue: 27
Pages: 19593-19603
DOI
Related Report
Peer Reviewed
-
-
-
-
-
[Book] 血液内科2014
Author(s)
家口勝昭、丸義朗
Total Pages
7
Publisher
科学評論社
Related Report
-
-